Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The global biopharmaceutical industry is the most rapidly growing industry in the science and technology sector owing to increasing R&D investments in biopharmaceutical drug development facilities. The global automation market in biopharmaceutical industry includes deployment of automation in biopharmaceutical academic research centers, manufacturing and research companies, clinical labs, and government approved labs.
One trend in the market is continuous manufacturing. Advantages of continuous operations are well-recognized in various industries. It completes the process in a shorter time as it omits the hold steps, reduces shut down time, and reduces the labor requirement. Over the decades, upstream processing utilized this technology.”According to the report, one driver in the market is use of automation in data acquisition. Traditionally, research labs collect data manually and store it in spreadsheets. This method is not only time-consuming but also affects operational efficiency and is prone to errors. It also restricts monitoring of data in real time. The biopharmaceutical industry is working on data collection and adding the information from spreadsheets to a database. Database collection of upstream and downstream processes is being utilized to create a library that increases operational efficiency and process optimization.Further, the report states that one challenge in the market is high R&D cost. The biopharmaceutical industry is a rapidly growing industry in pharmaceuticals. Complex drugs are manufactured with the help of 3-D modeling and are produced with high efficacy and precision. These drugs can provide medication to medical issues that were once incurable. Currently, the biopharmaceutical industry is looking to yield new products to address diseases such as cancer, Alzheimer's disease, and hepatitis C. Innovations in the biopharmaceutical industry are highly expensive. The average cost associated with a new drug is around $2 billion, including the cost of unsuccessful drug approvals, out of which almost $400 million is the cost included in pre-clinical and clinical testing.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Automation in Biopharmaceutical market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Automation in Biopharmaceutical market. Detailed analysis of key players, along with key growth strategies adopted by Automation in Biopharmaceutical industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Peak Analysis & Automation
Tecan Trading
Bruker
Capsugel
PerkinElmer
Eirechrom
Danaher
GE
Novasep
Waters
Thermo Fisher Scientific
BioProcess International
RheoSense
By Type:
Clinical stage automation
Drug discovery stage automation
By End-User:
Research and Development
Clinical
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Automation in Biopharmaceutical Market
-
1.3 Market Segment by Type
-
1.3.1 USA Automation in Biopharmaceutical Market Size and Growth Rate of Clinical stage automation from 2016 to 2027
-
1.3.2 USA Automation in Biopharmaceutical Market Size and Growth Rate of Drug discovery stage automation from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Automation in Biopharmaceutical Market Size and Growth Rate of Research and Development from 2016 to 2027
-
1.4.2 USA Automation in Biopharmaceutical Market Size and Growth Rate of Clinical from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Automation in Biopharmaceutical Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Automation in Biopharmaceutical Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Automation in Biopharmaceutical Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Automation in Biopharmaceutical Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Automation in Biopharmaceutical Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Automation in Biopharmaceutical by Major Types
-
3.4.1 Market Size and Growth Rate of Clinical stage automation
-
3.4.2 Market Size and Growth Rate of Drug discovery stage automation
4 Segmentation of Automation in Biopharmaceutical Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Automation in Biopharmaceutical by Major End-Users
-
4.4.1 Market Size and Growth Rate of Automation in Biopharmaceutical in Research and Development
-
4.4.2 Market Size and Growth Rate of Automation in Biopharmaceutical in Clinical
5 Market Analysis by Regions
-
5.1 USA Automation in Biopharmaceutical Production Analysis by Regions
-
5.2 USA Automation in Biopharmaceutical Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Automation in Biopharmaceutical Landscape Analysis
-
6.1 West USA Automation in Biopharmaceutical Landscape Analysis by Major Types
-
6.2 West USA Automation in Biopharmaceutical Landscape Analysis by Major End-Users
7 South USA Automation in Biopharmaceutical Landscape Analysis
-
7.1 South USA Automation in Biopharmaceutical Landscape Analysis by Major Types
-
7.2 South USA Automation in Biopharmaceutical Landscape Analysis by Major End-Users
8 Middle West USA Automation in Biopharmaceutical Landscape Analysis
-
8.1 Middle West USA Automation in Biopharmaceutical Landscape Analysis by Major Types
-
8.2 Middle West USA Automation in Biopharmaceutical Landscape Analysis by Major End-Users
9 Northeast USA Automation in Biopharmaceutical Landscape Analysis
-
9.1 Northeast USA Automation in Biopharmaceutical Landscape Analysis by Major Types
-
9.2 Northeast USA Automation in Biopharmaceutical Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Peak Analysis & Automation
-
10.1.1 Peak Analysis & Automation Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Tecan Trading
-
10.2.1 Tecan Trading Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Bruker
-
10.3.1 Bruker Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Capsugel
-
10.4.1 Capsugel Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 PerkinElmer
-
10.5.1 PerkinElmer Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Eirechrom
-
10.6.1 Eirechrom Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Danaher
-
10.7.1 Danaher Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 GE
-
10.8.1 GE Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Novasep
-
10.9.1 Novasep Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Waters
-
10.10.1 Waters Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 Thermo Fisher Scientific
-
10.11.1 Thermo Fisher Scientific Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
-
10.12 BioProcess International
-
10.12.1 BioProcess International Company Profile and Recent Development
-
10.12.2 Market Performance
-
10.12.3 Product and Service Introduction
-
10.13 RheoSense
-
10.13.1 RheoSense Company Profile and Recent Development
-
10.13.2 Market Performance
-
10.13.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Automation in Biopharmaceutical Market Size and Growth Rate of Clinical stage automation from 2016 to 2027
-
Figure USA Automation in Biopharmaceutical Market Size and Growth Rate of Drug discovery stage automation from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Automation in Biopharmaceutical Market Size and Growth Rate of Research and Development from 2016 to 2027
-
Figure USA Automation in Biopharmaceutical Market Size and Growth Rate of Clinical from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Automation in Biopharmaceutical Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Automation in Biopharmaceutical Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Automation in Biopharmaceutical Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Automation in Biopharmaceutical Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Automation in Biopharmaceutical Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Automation in Biopharmaceutical
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Automation in Biopharmaceutical by Different Types from 2016 to 2027
-
Table Consumption Share of Automation in Biopharmaceutical by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Clinical stage automation
-
Figure Market Size and Growth Rate of Drug discovery stage automation
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Automation in Biopharmaceutical by Different End-Users from 2016 to 2027
-
Table Consumption Share of Automation in Biopharmaceutical by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Research and Development
-
Figure Market Size and Growth Rate of Clinical
-
Table USA Automation in Biopharmaceutical Production by Regions
-
Table USA Automation in Biopharmaceutical Production Share by Regions
-
Figure USA Automation in Biopharmaceutical Production Share by Regions in 2016
-
Figure USA Automation in Biopharmaceutical Production Share by Regions in 2021
-
Figure USA Automation in Biopharmaceutical Production Share by Regions in 2027
-
Table USA Automation in Biopharmaceutical Consumption by Regions
-
Table USA Automation in Biopharmaceutical Consumption Share by Regions
-
Figure USA Automation in Biopharmaceutical Consumption Share by Regions in 2016
-
Figure USA Automation in Biopharmaceutical Consumption Share by Regions in 2021
-
Figure USA Automation in Biopharmaceutical Consumption Share by Regions in 2027
-
Table West USA Automation in Biopharmaceutical Consumption by Types from 2016 to 2027
-
Table West USA Automation in Biopharmaceutical Consumption Share by Types from 2016 to 2027
-
Figure West USA Automation in Biopharmaceutical Consumption Share by Types in 2016
-
Figure West USA Automation in Biopharmaceutical Consumption Share by Types in 2021
-
Figure West USA Automation in Biopharmaceutical Consumption Share by Types in 2027
-
Table West USA Automation in Biopharmaceutical Consumption by End-Users from 2016 to 2027
-
Table West USA Automation in Biopharmaceutical Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Automation in Biopharmaceutical Consumption Share by End-Users in 2016
-
Figure West USA Automation in Biopharmaceutical Consumption Share by End-Users in 2021
-
Figure West USA Automation in Biopharmaceutical Consumption Share by End-Users in 2027
-
Table South USA Automation in Biopharmaceutical Consumption by Types from 2016 to 2027
-
Table South USA Automation in Biopharmaceutical Consumption Share by Types from 2016 to 2027
-
Figure South USA Automation in Biopharmaceutical Consumption Share by Types in 2016
-
Figure South USA Automation in Biopharmaceutical Consumption Share by Types in 2021
-
Figure South USA Automation in Biopharmaceutical Consumption Share by Types in 2027
-
Table South USA Automation in Biopharmaceutical Consumption by End-Users from 2016 to 2027
-
Table South USA Automation in Biopharmaceutical Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Automation in Biopharmaceutical Consumption Share by End-Users in 2016
-
Figure South USA Automation in Biopharmaceutical Consumption Share by End-Users in 2021
-
Figure South USA Automation in Biopharmaceutical Consumption Share by End-Users in 2027
-
Table Middle West USA Automation in Biopharmaceutical Consumption by Types from 2016 to 2027
-
Table Middle West USA Automation in Biopharmaceutical Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Automation in Biopharmaceutical Consumption Share by Types in 2016
-
Figure Middle West USA Automation in Biopharmaceutical Consumption Share by Types in 2021
-
Figure Middle West USA Automation in Biopharmaceutical Consumption Share by Types in 2027
-
Table Middle West USA Automation in Biopharmaceutical Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Automation in Biopharmaceutical Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Automation in Biopharmaceutical Consumption Share by End-Users in 2016
-
Figure Middle West USA Automation in Biopharmaceutical Consumption Share by End-Users in 2021
-
Figure Middle West USA Automation in Biopharmaceutical Consumption Share by End-Users in 2027
-
Table Northeast USA Automation in Biopharmaceutical Consumption by Types from 2016 to 2027
-
Table Northeast USA Automation in Biopharmaceutical Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Automation in Biopharmaceutical Consumption Share by Types in 2016
-
Figure Northeast USA Automation in Biopharmaceutical Consumption Share by Types in 2021
-
Figure Northeast USA Automation in Biopharmaceutical Consumption Share by Types in 2027
-
Table Northeast USA Automation in Biopharmaceutical Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Automation in Biopharmaceutical Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Automation in Biopharmaceutical Consumption Share by End-Users in 2016
-
Figure Northeast USA Automation in Biopharmaceutical Consumption Share by End-Users in 2021
-
Figure Northeast USA Automation in Biopharmaceutical Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Peak Analysis & Automation
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Peak Analysis & Automation
-
Figure Sales and Growth Rate Analysis of Peak Analysis & Automation
-
Figure Revenue and Market Share Analysis of Peak Analysis & Automation
-
Table Product and Service Introduction of Peak Analysis & Automation
-
Table Company Profile and Development Status of Tecan Trading
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tecan Trading
-
Figure Sales and Growth Rate Analysis of Tecan Trading
-
Figure Revenue and Market Share Analysis of Tecan Trading
-
Table Product and Service Introduction of Tecan Trading
-
Table Company Profile and Development Status of Bruker
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bruker
-
Figure Sales and Growth Rate Analysis of Bruker
-
Figure Revenue and Market Share Analysis of Bruker
-
Table Product and Service Introduction of Bruker
-
Table Company Profile and Development Status of Capsugel
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Capsugel
-
Figure Sales and Growth Rate Analysis of Capsugel
-
Figure Revenue and Market Share Analysis of Capsugel
-
Table Product and Service Introduction of Capsugel
-
Table Company Profile and Development Status of PerkinElmer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of PerkinElmer
-
Figure Sales and Growth Rate Analysis of PerkinElmer
-
Figure Revenue and Market Share Analysis of PerkinElmer
-
Table Product and Service Introduction of PerkinElmer
-
Table Company Profile and Development Status of Eirechrom
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eirechrom
-
Figure Sales and Growth Rate Analysis of Eirechrom
-
Figure Revenue and Market Share Analysis of Eirechrom
-
Table Product and Service Introduction of Eirechrom
-
Table Company Profile and Development Status of Danaher
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Danaher
-
Figure Sales and Growth Rate Analysis of Danaher
-
Figure Revenue and Market Share Analysis of Danaher
-
Table Product and Service Introduction of Danaher
-
Table Company Profile and Development Status of GE
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GE
-
Figure Sales and Growth Rate Analysis of GE
-
Figure Revenue and Market Share Analysis of GE
-
Table Product and Service Introduction of GE
-
Table Company Profile and Development Status of Novasep
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novasep
-
Figure Sales and Growth Rate Analysis of Novasep
-
Figure Revenue and Market Share Analysis of Novasep
-
Table Product and Service Introduction of Novasep
-
Table Company Profile and Development Status of Waters
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Waters
-
Figure Sales and Growth Rate Analysis of Waters
-
Figure Revenue and Market Share Analysis of Waters
-
Table Product and Service Introduction of Waters
-
Table Company Profile and Development Status of Thermo Fisher Scientific
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Thermo Fisher Scientific
-
Figure Sales and Growth Rate Analysis of Thermo Fisher Scientific
-
Figure Revenue and Market Share Analysis of Thermo Fisher Scientific
-
Table Product and Service Introduction of Thermo Fisher Scientific
-
Table Company Profile and Development Status of BioProcess International
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioProcess International
-
Figure Sales and Growth Rate Analysis of BioProcess International
-
Figure Revenue and Market Share Analysis of BioProcess International
-
Table Product and Service Introduction of BioProcess International
-
Table Company Profile and Development Status of RheoSense
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of RheoSense
-
Figure Sales and Growth Rate Analysis of RheoSense
-
Figure Revenue and Market Share Analysis of RheoSense
-
Table Product and Service Introduction of RheoSense
-
